ATTENDING ONCOLOGIST Edward Lin , MD . 
IDENTIFICATION Mr. James Wheeler is a 72 - year - old gentleman initially diagnosed with T3N1 rectal carcinoma in 2012 , s/p LAR followed by adjuvant FOLFOX and chemoradiation therapy . 
He was recently found to have disease recurrence consisting of a new obstructing lesion in the colon as well as a new pulmonary nodule consistent with metastasis . 
He returns today for neoadjuvant chemotherapy and is seen in clinic prior to infusion for assessment and lab review . 
CURRENT TREATMENT FOLFIRI plus Avastin . 
Today is cycle 1 day 1 . 
HISTORY OF PRESENT ILLNESS 1 . 
Diagnosed with locally advanced rectal carcinoma , December 2012 , and colonoscopy found a large villous adenoma ; 1 cm from the anal verge . 
A transanal excision revealed rectal carcinoma , and endoscopic ultrasound revealed the tumor was limited to just the simple mucosa . 
However , PET scan showed highly suspicious lymph nodes . 2 . 
On January 24 , 2013 , the patient underwent laparoscopic abdominoperineal resection with a 2.5 cm tumor invading the muscularis propria , and no lymphovascular invasion noted . 
Margins were otherwise negative . 
3 of 13 lymph nodes showed regional metastasis , and there were some tumor infiltrating lymphocytes present . 
3 . 
The patient began FOLFOX chemotherapy on February 26 , 2013 , times 5 cycles , with the last cycle administered on April 23 , 2013 . 
4 . 
The patient then transition chemotherapy to chemoradiation therapy with oral capecitabine on May 7 , 2013 , completed in mid June . 
5 . 
FOLFOX chemotherapy was initiated in July 23 , 2013 . 
The patient required modification of FOLFOX chemotherapy with removal of the oxaliplatin on his cycle # 7 of planned 10 cycles . 
6 . 
September 17 , 2014 - June 2014 : Surveillance . 
7 . 
June 24 , 2014 : 
Colonoscopy reveals large nearly obstructing colon mass . 
Pathology confirms moderately differentiated adenocarcinoma with mucinous features . 
8 . 
July 16 , 2014 : 
Reinitiation of FOLFOX chemotherapy in the neoadjuvant setting . 
INTERVAL HISTORY 
Patient seen today prior to restarting FOLFOX chemotherapy . 
He reports continued lower abdominal cramping pain , worse at night , somewhat relieved by bowel movements . 
He treats with Aleve , senna QHS , with moderate relief . 
Pain is not limiting ADLs and his ostomy continues to function well . 
He is understandably anxious about his cancer recurrence and is anxious to proceed . 
Denies fevers or chills , chest pain or chest tightness , SOB , cough , nausea , vomiting , diarrhea , constipation , skin rash , mouth sores . 
No falls or near falls . 
ECOG performance status is 1 . 
PAST MEDICAL HISTORY 1 . 
BPH . 2 . 
Hypertension . 
3 . Gout . 
4 . 
Rectal cancer as above . 
PAST SURGICAL HISTORY 1 . 
Transanal endoscopic microsurgery . 
2 . 
Abdominoperineal resection as above . 
ALLERGIES 
NO KNOWN DOCUMENTED ALLERGIES . 
MEDICATIONS 1 . 
Allopurinol 300 mg PO daily 2 . 
Tamsulosin 0.4 mg 2 tablets PO every morning 3 . 
Lisinopril 40 mg PO daily . 
4 . 
Multivitamin PO daily . 
5 . 
Senna QHS . 
6 . 
Aleve 2 tabs QHS 7 . 
Lorazepam 1 mg 3 tabs PO QHS . 
8 . 
Emla cream to port pre - access . 
9 . 
Triamcinalone cream to back rash prn pruritis . 
10 . 
Amlodipine 5 mg PO daily ( added today ) . 
PHYSICAL EXAMINATION GENERAL : WDWN male in NAD . 
Pleasant , appropriate , accompanied by his wife . 
VITAL SIGNS : 
Temperature : 36.8 Pulse : 93 Blood Pressure : 160 / 79 Respirations : 16 Height : 176 . 
5cm Weight : 93 . 
1kg GENERAL : WDWN . 
NAD . 
Mood is good , affect is normal . 
Accompanied by VITAL SIGNS : Temperature , heart rate , respiratory rate 16 , blood pressure . 
Wt kg . 
HEENT : Sclerae anicteric , non - injected . 
Oral mucosa pink and moist without lesions . 
HEART : Regular rate and rhythm . 
No murmurs , rubs , gallops . 
No peripheral edema . 
LUNGS : Clear to auscultation bilaterally . 
No wheezes or rales . 
ABDOMEN : Ostomy site is pink , clear , without surrounding erythema . 
Bowel sounds are present . 
No organomegaly noted . 
SKIN : No rashes , erythema or dryness . 
EXTREMITIES : 
No clubbing or cyanosis . 
Normal muscle tone . 
NEURO 
: A & Ox3 . 
Cranial nerves grossly intact . 
LABS Laboratory Results ( Last result for the prior 7 days ) 07/16/2014 Na 138 K 4.1 Cl 104 CO2 27 Glucose Level 96 BUN 13 Creatinine 0.88 Ca 9.4 LD ( Total ) 134 AST ( GOT ) 19 ALT ( GPT ) 19 Alk Phos ( Total ) 87 Bilirubin ( Total ) 0.7 Bilirubin ( Direct ) 0.1 Protein ( Total ) 7.2 Albumin 4.0 WBC 5.93 RBC 4.59 Hb 13.8 HCT 40 PLT 173 Neutrophils 3.79 ( Last 3 results for the prior 6 months ) Result / Date Result / Date Result / Date Carcinoembryonic Antigen 9.7 ( 07/16/14 ) 8.6 ( 07/07/14 ) 3.2 ( 06/03/14 ) 
CA 
19 - 9 Pending ( 07/16/14 ) 57 ( 06/03/14 ) 36 ( 03/11/14 ) ASSESSMENT / PLAN 1 . 
Treatment . 
Based on his ECOG performance status of 1 and his labs , we will proceed with chemotherapy as scheduled today . 
Plan for neoadjuvant therapy with possibility of performing surgical resection , most likely consisting of completion colectomy and end ileostomy and repair of peristomal hernia . 
2 . 
Chemo toxicities . 
Reviewed today , and he will have a full chemo teach session following our visit . 
He will receive prescriptions for supportive meds , and was reminded to contact us with any questions or concerns . 
3 . 
Chemo - induced peripheral neuropathy . 
He does have a history of this following previous oxaliplatin therapy , now currently resolved . 
Will need to monitor closely . 
4 . 
Pain , bilateral lower abdomen . 
Managing well with Aleve and bowel meds . 
Symptoms may likely improve as we proceed with treatment . 
Monitor and adjust meds as needed . 
5 . 
Hypertension . 
The patient is on lisinopril , although he is hypertensive in clinic today . 
Will recheck in infusion suite and hold Avastin as needed , which was explained to the patient today . 
He indicates understanding . 
Will also add amlodipine 5 mg PO daily , and he was asked to monitor his BPs at home daily and monitor for dizziness , lightheadedness . 
Reassess in two weeks . 
Dispo - Scheduled to RTC on July 31 st for cycle 2 and a visit with Dr. Lin . 
